189 EFFECT OF IRON CHELATION THERAPY WITH DEFERASIROX (EXJADE®, ICL670) OR DEFEROXAMINE ON HEPATOCELLULAR INFLAMMATION AND LIVER FUNCTION IN PATIENTS WITH TRANSFUSIONDEPENDENT ANEMIA

Yves Deugnier(Inserm), Pierre Brissot(Inserm), B. Rabault(Novartis (Switzerland)), Madeleine Ropert-Bouchet(Inserm), Bruno Turlin(Inserm)
Journal of Hepatology
January 1, 2008
Cited by 3


Related Papers